Evaluation of the Feasibility of a Study Comparing Local Anesthesia and General Anesthesia in Conservative Surgery for Breast Cancer

NCT ID: NCT06910280

Last Updated: 2025-04-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-31

Study Completion Date

2026-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The conservative surgery for breast cancer is the first treatment for cancer and includes :

* A partial mastectomy (removal of part of the breast)
* A sentinel lymph node analysis, depending on the case (analysis of the first lymph node(s) draining the affected breast).

This is a common procedure in the gynecology operating room, usually performed under general anesthesia. However, with surgical advancements and less invasive procedures, it has become possible and common for patients to undergo surgery in our department under local anesthesia. No data in the medical literature has yet evaluated this new anesthetic approach.

Through this study, we aim to assess the feasibility and acceptability of partial mastectomy surgery with sentinel lymph node removal under either local anesthesia or general anesthesia.

The ultimate goal of this study is to allow future patients to benefit from faster outpatient surgery, requiring less hospital stay, and to continue the progress of minimizing surgical interventions that has already been successfully undertaken in breast cancer treatment.

This is an interventional study because it involves randomization, which determines for each enrolled patient whether they will receive general anesthesia or local anesthesia. It is a feasibility and acceptability study

It is important to note that the surgery itself will not differ between the two groups: only the method of anesthesia will change. This research is being conducted at the University Hospital of Besançon and only at this center.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

With local anesthesia

local anesthesia

Group Type EXPERIMENTAL

conservative surgery for breast cancer with local anesthesia

Intervention Type PROCEDURE

conservative surgery for breast cancer with local anesthesia

With general anesthesia

general anesthesia

Group Type ACTIVE_COMPARATOR

conservative surgery for breast cancer with general anesthesia

Intervention Type PROCEDURE

conservative surgery for breast cancer with general anesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

conservative surgery for breast cancer with local anesthesia

conservative surgery for breast cancer with local anesthesia

Intervention Type PROCEDURE

conservative surgery for breast cancer with general anesthesia

conservative surgery for breast cancer with general anesthesia

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female over 18 years of age
* Diagnosis of invasive breast cancer (histological proof via breast biopsy)
* Tumor size less than or equal to clinical T2 according to the current cTNM classification for breast cancer"
* No clinical and/or radiological evidence of lymph node involvement
* Affiliation to a French social security scheme or beneficiary of such a scheme
* Approval in the multidisciplinary tumor board meeting for conservative treatment with partial mastectomy combined with sentinel lymph node biopsy
* Signed informed consent indicating that the patient understands the purpose and procedures required by the study and agrees to participate in the study and comply with its requirements and restrictions

Exclusion Criteria

* Severe and morbid obesity (BMI strictly greater than 35)
* Emaciation (BMI strictly less than 18.5)
* Contraindication to the medications used in the protocol
* Contraindication to general anesthesia
* Contraindication to the local anesthesia protocol
* Tumor considered non-resectable under local anesthesia according to the surgeon's assessment
* Bifocal tumor
* Associated oncoplastic procedure
* Contralateral surgical procedure (implantable port placement, mastopexy, partial or total mastectomy)
* Withdrawal of consent prior to surgery
* Legal incapacity or limited legal capacity
* Non-fluency in the French language or poor understanding as anticipated by the investigator
* Subject without health insurance
* Pregnant woman
* Subject currently in the exclusion period of another study or listed in the national volunteer registry
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Besancon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Besancon

Besançon, Franche Comte, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

PIERRE BEDAT

Role: primary

+330381218113

References

Explore related publications, articles, or registry entries linked to this study.

Seror J, Hequet D, Gout-Duracher C, Cittanova M laure. Faisabilité et impact de la chirurgie mammaire conservatrice sous anesthésie locale. Communication orale, Congrè SFSPM; 2022.

Reference Type BACKGROUND

Karanlik H, Kilic B, Yildirim I, Bademler S, Ozgur I, Ilhan B, Onder S. Breast-Conserving Surgery Under Local Anesthesia in Elderly Patients with Severe Cardiorespiratory Comorbidities: A Hospital-Based Case-Control Study. Breast Care (Basel). 2017 Mar;12(1):29-33. doi: 10.1159/000455003. Epub 2017 Feb 8.

Reference Type BACKGROUND
PMID: 28611538 (View on PubMed)

Hirokawa T, Kinoshita T, Nagao T, Hojo T. A clinical trial of curative surgery under local anesthesia for early breast cancer. Breast J. 2012 Mar-Apr;18(2):195-7. doi: 10.1111/j.1524-4741.2011.01221.x. Epub 2012 Feb 2. No abstract available.

Reference Type BACKGROUND
PMID: 22300192 (View on PubMed)

Carlson GW. Total mastectomy under local anesthesia: the tumescent technique. Breast J. 2005 Mar-Apr;11(2):100-2. doi: 10.1111/j.1075-122X.2005.21536.x.

Reference Type BACKGROUND
PMID: 15730454 (View on PubMed)

Sleth JC, Lavie M, Mion P, Saizy C, Servais R. [Tumescent local anaesthesia for mastectomy: lidocaine plasma concentration]. Ann Fr Anesth Reanim. 2006 Jan;25(1):74-6. doi: 10.1016/j.annfar.2005.07.074. Epub 2005 Oct 26. No abstract available. French.

Reference Type BACKGROUND
PMID: 16256296 (View on PubMed)

Saint-Roch P. L'anesthésie locale tumescente a-t-elle une place ? 2013;

Reference Type BACKGROUND

Anne-Pauline Cungi. Étude Hypno-Séno : anesthésie générale versus hypno-tumescence en chirurgie mammaire conservatrice : évaluation de la qualité des marges de résection chirurgicale. 2020;

Reference Type BACKGROUND

Sleth JC, Servais R, Saizy C. [Tumescent infiltrative anaesthesia for mastectomy: about six cases]. Ann Fr Anesth Reanim. 2008 Nov;27(11):941-4. doi: 10.1016/j.annfar.2008.08.011. Epub 2008 Nov 11. French.

Reference Type BACKGROUND
PMID: 19004607 (View on PubMed)

Ceccarino R, Di Micco R, Cappelletti R. Aesthetic Breast Surgery Under Cold Tumescent Anesthesia: Feasibility and Safety in Outpatient Clinic. Ann Plast Surg. 2019 Oct;83(4):384-387. doi: 10.1097/SAP.0000000000001798.

Reference Type BACKGROUND
PMID: 31524728 (View on PubMed)

Boeer B, Helms G, Pasternak J, Roehm C, Kofler L, Haefner HM, Moehrle M, Heim E, Fischer H, Brucker SY, Hahn M. Back to the future: breast surgery with tumescent local anesthesia (TLA)? Arch Gynecol Obstet. 2023 Sep;308(3):935-940. doi: 10.1007/s00404-023-06938-5. Epub 2023 Mar 6.

Reference Type BACKGROUND
PMID: 36872392 (View on PubMed)

Groetelaers RP, van Berlo CL, Nijhuis PH, Schapers RF, Gerritsen HA. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years. Eur J Surg Oncol. 2009 Feb;35(2):159-63. doi: 10.1016/j.ejso.2008.07.017. Epub 2008 Sep 11.

Reference Type BACKGROUND
PMID: 18789841 (View on PubMed)

van Berlo CL, Hess DA, Nijhuis PA, Leys E, Gerritsen HA, Schapers RF. Ambulatory sentinel node biopsy under local anaesthesia for patients with early breast cancer. Eur J Surg Oncol. 2003 May;29(4):383-5. doi: 10.1053/ejso.2002.1420.

Reference Type BACKGROUND
PMID: 12711294 (View on PubMed)

Luini A, Gatti G, Frasson A, Naninato P, Magalotti C, Arnone P, Viale G, Pruneri G, Galimberti V, De Cicco C, Veronesi U. Sentinel lymph node biopsy performed with local anesthesia in patients with early-stage breast carcinoma. Arch Surg. 2002 Oct;137(10):1157-60. doi: 10.1001/archsurg.137.10.1157.

Reference Type BACKGROUND
PMID: 12361425 (View on PubMed)

Luini A, Caldarella P, Gatti G, Veronesi P, Vento AR, Naninato P, Arnone P, Sangalli C, Brenelli F, Sosnovskikh I, Peradze N, Dussan Luberth CA, Viale G, Paganelli G. The sentinel node biopsy under local anesthesia in breast cancer: advantages and problems, how the technique influenced the activity of a breast surgery department; update from the European Institute of Oncology with more than 1000 cases. Breast. 2007 Oct;16(5):527-32. doi: 10.1016/j.breast.2007.04.003.

Reference Type BACKGROUND
PMID: 17916496 (View on PubMed)

Luini A, Gatti G, Zurrida S, Galimberti V, Paganelli G, Naninato P, Caldarella P, Rotmensz N, Winnikow E, Viale G. The sentinel lymph node biopsy under local anesthesia in breast carcinoma: experience of the European Institute of Oncology and impact on quality of life. Breast Cancer Res Treat. 2005 Jan;89(1):69-74. doi: 10.1007/s10549-004-1473-y.

Reference Type BACKGROUND
PMID: 15666199 (View on PubMed)

Kongdan Y, Chirappapha P, Lertsithichai P. Effectiveness and reliability of sentinel lymph node biopsy under local anesthesia for breast cancer. Breast. 2008 Oct;17(5):528-31. doi: 10.1016/j.breast.2008.04.003. Epub 2008 Jun 2.

Reference Type BACKGROUND
PMID: 18515105 (View on PubMed)

Gauthier T, Garuchet-Bigot A, Mollard J, Aubard Y. [How I... remove axillary sentinel lymph node under local anesthesia]. Gynecol Obstet Fertil. 2010 Jun;38(6):418-9. doi: 10.1016/j.gyobfe.2010.04.004. Epub 2010 Jun 4. No abstract available. French.

Reference Type BACKGROUND
PMID: 20576555 (View on PubMed)

Fenaroli P, Tondini C, Motta T, Virotta G, Personeni A. Axillary sentinel node biopsy under local anaesthesia in early breast cancer. Ann Oncol. 2000 Dec;11(12):1617-8. doi: 10.1093/oxfordjournals.annonc.a010407. No abstract available.

Reference Type BACKGROUND
PMID: 11205475 (View on PubMed)

Institut national du cancer. Traitements locorégionaux des cancers du sein infiltrants non métastatiques / Synthèse, collection Recomman- dations et référentiels. 2022.

Reference Type BACKGROUND

HAS. Haute Autorité de Santé. Infracyanine (vert d'indocyanine monopic) - Repérage peropératoire du ganglion sentinelle. 2022.

Reference Type BACKGROUND

Lucas N, Interne SB, Laine P, Nicolie B, Fondrinier E. [Anaphylactic shock due to patent blue: four case report and review of literature]. J Gynecol Obstet Biol Reprod (Paris). 2010 Apr;39(2):116-20. doi: 10.1016/j.jgyn.2009.10.006. Epub 2010 Jan 15. French.

Reference Type BACKGROUND
PMID: 20079974 (View on PubMed)

C. Ngô, C. Nos, A.-S. Bats, C. Bensaid, F. Lécuru. Chirurgie locorégional des cancers du sein. In: Encyclopédie Médico-chirurgicale. Elsevier-Masson. 2020.

Reference Type BACKGROUND

Modi S, Saura C, Yamashita T, Park YH, Kim SB, Tamura K, Andre F, Iwata H, Ito Y, Tsurutani J, Sohn J, Denduluri N, Perrin C, Aogi K, Tokunaga E, Im SA, Lee KS, Hurvitz SA, Cortes J, Lee C, Chen S, Zhang L, Shahidi J, Yver A, Krop I; DESTINY-Breast01 Investigators. Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer. N Engl J Med. 2020 Feb 13;382(7):610-621. doi: 10.1056/NEJMoa1914510. Epub 2019 Dec 11.

Reference Type BACKGROUND
PMID: 31825192 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024/927

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.